Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Levy

Showing results (191-200 of 2,940) with videos related to

Pageof 294
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulationG A Levy
Journal of the American Podiatric Medical Association|April 1, 1992
Prevalence of chronic podiatric conditions in the US. National Health Survey 1990L A Levy
Infectious Disease Clinics of North America|June 1, 1988
The human immunodeficiency virus and its pathogenesisJ A Levy
The New England Journal of Medicine|February 14, 2009
Not an HIV cure, but encouraging new directionsJay A Levy
Clinics in Podiatric Medicine and Surgery|January 1, 1992
Smoking and peripheral vascular disease. Podiatric medical updateL A Levy
The Journal of Rheumatology|June 1, 1975
Xenotropic C-type viruses and autoimmune diseaseJ A Levy
Journal of the American Podiatry Association|September 1, 1973
The natural history of podiatric disorders--establishing priorities for our profession and its teaching institutionsL A Levy
New York State Journal of Medicine|October 29, 2010
Comments on war neurosesN A LEVY
Microbiological Reviews|March 1, 1993
Pathogenesis of human immunodeficiency virus infectionJ A Levy
Journal of the American Podiatric Medical Association|October 29, 1998
The impact of tobacco use on podiatric medicineL A Levy
Pageof 294

Showing results (191-200 of 2,940) with videos related to

Sort By:
Pageof 294
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulationG A Levy
Journal of the American Podiatric Medical Association|April 1, 1992
Prevalence of chronic podiatric conditions in the US. National Health Survey 1990L A Levy
Infectious Disease Clinics of North America|June 1, 1988
The human immunodeficiency virus and its pathogenesisJ A Levy
The New England Journal of Medicine|February 14, 2009
Not an HIV cure, but encouraging new directionsJay A Levy
Clinics in Podiatric Medicine and Surgery|January 1, 1992
Smoking and peripheral vascular disease. Podiatric medical updateL A Levy
The Journal of Rheumatology|June 1, 1975
Xenotropic C-type viruses and autoimmune diseaseJ A Levy
Journal of the American Podiatry Association|September 1, 1973
The natural history of podiatric disorders--establishing priorities for our profession and its teaching institutionsL A Levy
New York State Journal of Medicine|October 29, 2010
Comments on war neurosesN A LEVY
Microbiological Reviews|March 1, 1993
Pathogenesis of human immunodeficiency virus infectionJ A Levy
Journal of the American Podiatric Medical Association|October 29, 1998
The impact of tobacco use on podiatric medicineL A Levy
Pageof 294